See more : Roadman Investments Corp. (RMANF) Income Statement Analysis – Financial Results
Complete financial analysis of Empower Clinics Inc. (EPWCF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Empower Clinics Inc., a leading company in the Medical – Care Facilities industry within the Healthcare sector.
You may be interested
- BayWa Aktiengesellschaft (0AH7.L) Income Statement Analysis – Financial Results
- Cassava Sciences, Inc. Warrant (SAVAW) Income Statement Analysis – Financial Results
- EBR Systems, Inc. (EBRCZ) Income Statement Analysis – Financial Results
- Asian Hotels (East) Limited (AHLEAST.NS) Income Statement Analysis – Financial Results
- Vardhman Special Steels Limited (VSSL.NS) Income Statement Analysis – Financial Results
Empower Clinics Inc. (EPWCF)
About Empower Clinics Inc.
Empower Clinics Inc., an integrated healthcare company, provides body and mind wellness services for patients through digital and telemedicine care, and medical diagnostics laboratories in the United States and Canada. The company operates a pipeline of 33 clinics in Alberta, British Columbia, and New Brunswick. It has a strategic alliance with SoLVBL Solutions Inc. to develop a program for data security in diagnostic testing. Empower Clinics Inc. is based in Vancouver, Canada.
| Metric | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 4.66M | 4.37M | 3.21M | 2.03M | 1.09M | 1.56M | 2.13K | 0.00 | 17.00K | 17.00K | 1.89M | 1.32M | 912.60K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 2.69M | 3.02M | 1.19M | 826.28K | 417.05K | 768.90K | 718.11 | 0.00 | 0.00 | 8.64M | 12.25M | 4.76M | 1.35M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 1.97M | 1.35M | 2.02M | 1.21M | 674.34K | 792.35K | 1.42K | 0.00 | 17.00K | -8.62M | -10.36M | -3.44M | -434.05K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit Ratio | 42.22% | 30.87% | 62.81% | 59.33% | 61.79% | 50.75% | 66.36% | 0.00% | 100.00% | -50,729.41% | -548.54% | -259.71% | -47.56% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 962.73K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 1.20M | 4.60M | 3.74M | 3.80M | 4.50M | 113.00K | 268.00K | 349.00K | 93.00K | 2.29M | 2.31M | 4.89M | 1.97M | 1.37M | 247.64K | 90.64K | 68.05K | 17.45K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 652.13K | 751.51K | 1.03M | 313.87K | 306.80K | 171.81 | 60.35 | 0.00 | 0.00 | 0.00 | 0.00 | 401.00K | 0.00 | 4.57K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 6.75M | 5.35M | 4.77M | 4.12M | 4.81M | 113.00K | 268.00K | 349.00K | 93.00K | 2.29M | 2.31M | 5.29M | 1.97M | 1.38M | 247.64K | 90.64K | 68.05K | 17.45K | 34.47K | 73.49K | 140.33K | 178.59K | 264.37K | 43.79K |
| Other Expenses | 173.07K | 1.41M | 850.85K | 604.31K | 829.43K | 0.00 | 0.00 | 23.02K | 469.00K | 765.00K | 3.52M | 4.84M | 1.22K | 5.88K | 37.54K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 730.76K | 856.23K | 64.85K |
| Operating Expenses | 6.92M | 6.75M | 5.62M | 4.72M | 4.98M | 113.00K | 268.00K | 349.00K | 562.00K | 3.06M | 5.83M | 5.29M | 2.94M | 1.38M | 285.18K | 90.64K | 68.05K | 17.45K | 34.47K | 73.49K | 140.33K | 909.34K | 1.12M | 108.63K |
| Cost & Expenses | 9.62M | 9.78M | 6.81M | 5.55M | 5.40M | 113.00K | 268.00K | 349.00K | 562.00K | 3.06M | 5.83M | 10.05M | 2.94M | 1.38M | 285.18K | 90.64K | 68.05K | 17.45K | 34.47K | 73.49K | 140.33K | 909.34K | 1.12M | 108.63K |
| Interest Income | 911.23K | 185.41K | 7.57K | 4.98K | 0.00 | 6.00K | 0.00 | 0.00 | 0.00 | 3.03M | 2.48M | 43.00K | 398.00 | 0.00 | 40.06K | 0.00 | 31.87K | 360.00 | 0.00 | 1.29K | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 1.55M | 185.41K | 539.41K | 355.05K | 367.90K | 0.00 | 0.00 | 0.00 | 0.00 | 30.00K | 745.00K | 109.00K | 0.00 | 0.00 | -285.18K | -90.64K | -35.40K | -18.75K | -64.09K | -341.81K | -137.40K | -893.77K | -1.11M | -108.63K |
| Depreciation & Amortization | 205.04K | 535.12K | 188.38K | 334.66K | 117.18K | 107.09K | 106.17K | 55.00K | 45.00K | 88.00K | 96.00K | 80.00K | 1.22K | 14.71K | 2.52K | 65.31K | 1.23K | 415.00 | 565.00 | 772.00 | 1.06K | 1.44K | 410.00 | 11.47K |
| EBITDA | -1.09M | -30.74M | -16.84M | -3.70M | -3.13M | -2.23M | -212.41K | -247.76K | 743.78K | -5.39M | -4.35M | -9.66M | -2.02M | -1.50M | -268.33K | 0.00 | -36.17K | -19.35K | -66.53K | -72.72K | -138.34K | -907.91K | -1.12M | -108.63K |
| EBITDA Ratio | -23.35% | -105.37% | -100.14% | -140.57% | -307.54% | -9.67% | -15,036.14% | 0.00% | -10,670.59% | 447.06% | -72.42% | -650.26% | -222.01% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Income | -4.95M | -5.41M | -3.61M | -3.52M | -4.31M | -113.00K | -268.00K | -349.00K | 772.00K | -8.64M | -12.25M | -9.95M | -2.03M | -1.38M | -285.18K | -90.64K | -68.05K | -17.45K | -34.47K | -73.49K | -140.33K | -893.77K | -1.11M | -108.63K |
| Operating Income Ratio | -106.28% | -123.75% | -112.35% | -173.02% | -394.85% | -7.24% | -12,553.53% | 0.00% | 4,541.18% | -50,829.41% | -648.54% | -752.23% | -222.14% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | 2.11M | -26.29M | -13.09M | -163.45K | 519.46K | -3.11M | -1.00K | 49.74K | 1.27M | -2.27M | -6.06M | -66.00K | 398.00 | 14.71K | 2.52K | 65.31K | 31.87K | -1.33K | -29.62K | -268.32K | 2.93K | 0.00 | 0.00 | 11.47K |
| Income Before Tax | -2.84M | -31.74M | -17.07M | -4.30M | -3.79M | -75.00K | -215.00K | -269.00K | 735.00K | -5.64M | -10.52M | -10.02M | -2.03M | -1.37M | -282.66K | -25.33K | -36.17K | -18.77K | -64.09K | -341.81K | -137.40K | -893.77K | -1.11M | -97.17K |
| Income Before Tax Ratio | -61.00% | -726.41% | -531.79% | -211.74% | -347.26% | -4.80% | -10,070.93% | 0.00% | 4,323.53% | -33,200.00% | -556.70% | -757.22% | -222.10% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | 165.00 | 968.67K | 542.21K | 812.18K | -519.46K | -38.00K | -53.00K | -55.00K | 37.00K | 2.61M | 41.00K | 33.00K | 6.22K | 1.37M | 282.66K | 25.33K | 36.17K | 18.77K | 64.09K | 341.81K | 137.40K | 893.77K | 1.11M | 97.17K |
| Net Income | -2.83K | -32.70M | -17.61M | -5.11M | -3.79M | -75.00K | -215.00K | -269.00K | 735.00K | -5.64M | -8.55M | -10.05M | -2.03M | -1.37M | -282.66K | -25.33K | -36.17K | -18.77K | -64.09K | -341.81K | -137.40K | -893.77K | -1.11M | -97.17K |
| Net Income Ratio | -0.06% | -748.58% | -548.69% | -251.72% | -347.26% | -4.80% | -10,070.93% | 0.00% | 4,323.53% | -33,200.00% | -452.83% | -759.71% | -222.78% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EPS | -0.04 | -0.50 | -0.48 | -0.22 | -0.28 | -0.02 | -0.06 | -0.09 | 0.30 | -2.34 | -4.83 | -7.55 | -2.43 | -3.89 | -0.91 | -0.08 | -0.13 | -0.08 | -0.29 | -1.44 | -0.53 | -3.75 | -5.25 | -0.75 |
| EPS Diluted | -0.04 | -0.50 | -0.48 | -0.22 | -0.28 | -0.02 | -0.06 | -0.09 | 0.30 | -2.34 | -4.83 | -7.55 | -2.43 | -3.89 | -0.91 | -0.08 | -0.13 | -0.08 | -0.29 | -1.44 | -0.53 | -3.75 | -5.25 | -0.75 |
| Weighted Avg Shares Out | 70.21M | 65.60M | 36.47M | 23.46M | 13.33M | 3.42M | 3.42M | 3.09M | 2.43M | 2.41M | 1.77M | 1.33M | 835.20K | 352.20K | 309.33K | 309.33K | 268.96K | 221.33K | 221.33K | 237.88K | 261.33K | 238.34K | 210.76K | 129.55K |
| Weighted Avg Shares Out (Dil) | 70.21M | 65.60M | 36.47M | 23.46M | 13.33M | 3.42M | 3.42M | 3.09M | 2.43M | 2.41M | 1.77M | 1.33M | 835.20K | 352.20K | 309.33K | 309.33K | 268.96K | 221.33K | 221.33K | 237.88K | 261.33K | 238.34K | 210.76K | 129.55K |
Empower Clinics to acquire four operational Ontario clinics with 400,000 patient files
Empower Clinics Inc told investors it has entered into a non-binding term sheet to acquire 100% of 1814764 Ontario Limited (Sudbury Clinics), a leading healthcare group with four locations in Sudbury, Ontario and its surrounding area. The proposed C$4.8 million...
Empower Clinics says its Kai Medical Lab approved to administer coronavirus vaccinations in the US
Empower Clinics Inc. has announced that its Kai Medical Laboratory has received approval to be a coronavirus Pandemic Provider with the ability to administer coronavirus (COVID-19) vaccinations in the US.
Empower Clinics acquires four operational medical clinics in Ontario
Empower Clinics Inc has announced the proposed acquisition of 2873847 Ontario Inc. (Thornhill Clinics) and its four operational medical clinics in Thornhill, Ontario. Thornhill Clinics employs over 15 general practitioners across four clinics, and currently holds 200,000 patient files.
Empower Clinics opens its NEXT ‘The Medi-Collective' clinic in Ontario
Empower Clinics Inc has announced the grand opening of its NEXT "The Medi-Collective" (TMC) clinic in Etobicoke, Ontario. The company said the clinic currently is fully operational and accepting new patients and walk-in appointments.
Empower Clinics says subsidiary wins contract with British Columbia First Nations Health Authority to provide diabetic testing products
Empower Clinics Inc. has been awarded a contract with the British Columbia First Nations Health Authority (FNHA) to provide diabetic testing products for communities supported by the agency.
Empower Clinics subsidiary MediSure enters pilot with Care Group of Pharmacies to carry leading diabetes management medical devices
Empower Clinics Inc said its wholly-owned subsidiary Medi+Sure Canada Inc has entered into a pilot agreement with the Care Group of Pharmacies to carry MediSure diabetes management medical devices in their pharmacies. The integrated healthcare company said the products include...
Empower Clinics Subsidiary MediSure Enters into Pilot with Care Group of Pharmacies to Carry Leading Diabetes Management Medical Devices in Canada
Agreement demonstrates ability of newly acquired medical device subsidiary to advance diabetes management platform with pharmacy chains on a national scale. VANCOUVER BC / ACCESSWIRE / October 4, 2021 / EMPOWER CLINICS INC.
Empower Clinics and SoLVBL Solutions pen deal for data security program
Empower Clinics Inc, an integrated healthcare company, said it has signed a memorandum of understanding with data security firm SoLVBL Solutions Inc to develop a cyber security program to detect cyber attacks. SoLVBL, which has developed advanced capabilities for providing...
SoLVBL Solutions and Empower Clinics Sign Memorandum of Understanding (MoU) to Develop a Program for Data Security in Diagnostic Testing
Toronto, Ontario--(Newsfile Corp. - September 27, 2021) - SoLVBL Solutions Inc. (CSE: SOLV) ("SoLVBL Solutions" or the "Company") is pleased to announce it has signed a Memorandum of Understanding ("MoU") with Empower Clinics Inc. (CSE: CBDT) (FSE: 8EC) (OTCQB: EPWCF)...
Empower Clinics and SoLVBL Solutions Sign Memorandum of Understanding (MoU) to Develop a Program for Data Security in Diagnostic Testing
Enhanced Data Verification Will Augment Empower's Integrated Technology Services and Goals VANCOUVER BC / ACCESSWIRE / September 27, 2021 / EMPOWER CLINICS INC. (CSE:CBDT)(FRA:8EC)(OTCQB:EPWCF) ("Empower" or the "Company") an integrated healthcare company - serving patients through medical centers, telemedicine platforms...
Source: https://incomestatements.info
Category: Stock Reports